• Home

Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

Familial hypercholesterolemia

• Overview
• Symptoms
• Treatment
• Prevention

Definition:

A dominantly inherited genetic condition that results in markedly elevated LDL (low-density lipoprotein) cholesterol levels beginning at birth, and cause heart attacks at an early age.

Alternative Names:

Type II hyperlipoproteinemia; Hypercholesterolemic xanthomatosis; Low density lipoprotein receptor mutation

Causes, incidence, and risk factors:

Affected people have consistently high levels of low-density lipoprotein (LDL or "bad" cholesterol), which leads to premature atherosclerosis of the coronary arteries. Typically in affected men, heart attacks occur in their 40s to 50s, and 85% of men with this disorder have experienced a heart attack by age 60. The incidence of heart attacks in women with this disorder is also increased, but happens 10 years later than in men.

Individuals from families with a strong history of early heart attacks should be evaluated with a lipid screen. Proper diet, exercise, and the use of newer drugs can bring lipids (fats in the blood) down to safer levels.

The mutation that causes this genetic abnormality occurs on chromosome 19. It is possible for a person to inherit copies of the mutated gene for this disorder (one from each parent, making them genetically "homozygous").

In homozygous individuals the condition is more severe, and cholesterol values may exceed 600 mg/dL. These individuals develop waxy plaques (xanthomas) beneath the skin over their elbows, knees, buttocks. These are deposits of cholesterol in the skin. In addition, they develop deposits in tendons and around the cornea of the eye. Atherosclerosis begins before puberty and heart attacks and death may occur before age 30, or they may require highly invasive surgery such as a liver transplant.

Those who have inherited only one copy of the mutated gene (from one parent) are called heterozygous. These individuals may respond well to diet modifications combined with statin drugs.

• Review Date: 3/13/2006
• Reviewed By: Lamya Alarif, Ph.D., H.C.L.D., Immunology and Genetics Associates, McLean, VA. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.